Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer
Year: 2018
Type: article
Study design: Observational Study
Source: Gynecologic Oncology
Institution: Mayo Clinic
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2903544784
